Pia Rivetti di Val Cervo
Overview
Explore the profile of Pia Rivetti di Val Cervo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
529
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rivetti di Val Cervo P, Alessi E, Lastella M, La Greca A, Trotta F
BioDrugs
. 2024 Oct;
38(6):831-844.
PMID: 39404995
Background: Advanced therapy medicinal products (ATMPs) are an innovative output of biomedical research, characterized by a high level of uncertainty on long-term efficacy and safety, elevated price tags and often...
2.
Rivetti di Val Cervo P, Besusso D, Conforti P, Cattaneo E
Nat Rev Neurol
. 2021 Mar;
17(6):381-392.
PMID: 33658662
Human induced pluripotent stem cells (hiPSCs) were first generated in 2007, but the full translational potential of this valuable tool has yet to be realized. The potential applications of hiPSCs...
3.
Giorgio E, Lorenzati M, Rivetti di Val Cervo P, Brussino A, Cernigoj M, Della Sala E, et al.
Brain
. 2019 May;
142(7):1905-1920.
PMID: 31143934
Allele-specific silencing by RNA interference (ASP-siRNA) holds promise as a therapeutic strategy for downregulating a single mutant allele with minimal suppression of the corresponding wild-type allele. This approach has been...
4.
Vezzoli E, Caron I, Talpo F, Besusso D, Conforti P, Battaglia E, et al.
J Clin Invest
. 2019 May;
129(6):2390-2403.
PMID: 31063986
A disintegrine and metalloproteinase 10 (ADAM10) is implicated in synaptic function through its interaction with postsynaptic receptors and adhesion molecules. Here, we report that levels of active ADAM10 are increased...
5.
Rivetti di Val Cervo P, Romanov R, Spigolon G, Masini D, Martin-Montanez E, Toledo E, et al.
Nat Biotechnol
. 2017 Apr;
35(5):444-452.
PMID: 28398344
Cell replacement therapies for neurodegenerative disease have focused on transplantation of the cell types affected by the pathological process. Here we describe an alternative strategy for Parkinson's disease in which...
6.
Villaescusa J, Li B, Toledo E, Rivetti di Val Cervo P, Yang S, Stott S, et al.
EMBO J
. 2016 Jun;
35(18):1963-78.
PMID: 27354364
Pre-B-cell leukemia homeobox (PBX) transcription factors are known to regulate organogenesis, but their molecular targets and function in midbrain dopaminergic neurons (mDAn) as well as their role in neurodegenerative diseases...
7.
Rivetti di Val Cervo P, Lena A, Nicoloso M, Rossi S, Mancini M, Zhou H, et al.
Proc Natl Acad Sci U S A
. 2012 Jan;
109(4):1133-8.
PMID: 22228303
We investigated the expression of microRNAs (miRNAs) associated with replicative senescence in human primary keratinocytes. A cohort of miRNAs up-regulated in senescence was identified by genome-wide miRNA profiling, and their...
8.
Neuronal differentiation by TAp73 is mediated by microRNA-34a regulation of synaptic protein targets
Agostini M, Tucci P, Killick R, Candi E, Sayan B, Rivetti di Val Cervo P, et al.
Proc Natl Acad Sci U S A
. 2011 Dec;
108(52):21093-8.
PMID: 22160687
The p53-family member TAp73 is a transcription factor that plays a key role in many biological processes. Here, we show that p73 drives the expression of microRNA (miR)-34a, but not...
9.
Rivetti di Val Cervo P, Tucci P, Majid A, Lena A, Agostini M, Bernardini S, et al.
Blood
. 2009 Jun;
113(25):6498-9.
PMID: 19541840
No abstract available.